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We report novel keratin 5 and 14 gene mutations in four
unrelated German families with the localized subtype of
the dominantly inherited blistering disease epidermolysis
bullosa simplex Weber–Cockayne (MIM# 131800). The
mutations are located in the keratin 14 L12 linker region
(D273G), the keratin 5 L12 linker (M327K and D328H),
and the H1 domain of keratin 5 (P156L). These mutations
add to those previously reported and provide further
evidence of phenotype-genotype correlations in epi-
Epidermolysis bullosa simplex (EBS) is a group of geneticskin disorders with an autosomal dominant mode ofinheritance. The incidence of all types of the disease isµ1:50,000. The EBS group is characterized by intraepider-mal blister formation due to basal keratinocyte lysis. Blisters
are induced by minor mechanical stress and appear more frequently in
warm and humid weather. Generally, improvement of blistering occurs
with advancing age.
According to the severity of symptoms, EBS is subdivided into three
major subtypes. The most severe type of EBS is Dowling–Meara,
showing generalized herpetiform blistering beginning from birth,
accompanied by progressive palmo-plantar hyperkeratosis. Oral mucosal
involvement is common. In contrast to the other forms of EBS,
EBS-Dowling–Meara skin biopsies are ultrastructurally typified by
circumscribed clumps of keratin intermediate filaments (KIF) in basal
epidermal keratinocytes. The Koebner (K) type is associated with
milder generalized blistering. The mildest and most common form of
EBS is Weber–Cockayne (WC), with blistering restricted primarily to
the hands and feet (Fine et al, 1991); however, suction-induced blisters
in apparently unaffected nonacral skin of EBS-WC patients showed
the same histologic findings (Taylor et al, 1993)
In recent years the molecular basis of EBS began to become
apparent by means of molecular genetics and transgenic mouse models.
Subsequent sequence analysis of EBS patients revealed that point
mutations in the basal keratins K5 and K14 are clustered in distinct
regions of the central rod domain, leading to the discovery of different
genetic hotspots for each particular disease subtype (for review, see
Corden and McLean, 1996; Fuchs, 1996; Joseph and Rothnagel, 1996;
Korge and Krieg, 1996). Almost all EBS-Dowling–Meara mutations
are located in the highly conserved ends of the α-helical rod. EBS-K
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dermolysis bullosa simplex subtypes. The above
mutations in mildly affected patients underline the relev-
ance of the keratin linker regions for the epidermolysis
bullosa simplex Weber–Cockayne phenotype and keratin
filament integrity. In addition, they confirm that the gene
segments encoding the linker regions represent hotspots
for mutations. Key words: intermediate filaments/keratin
genes. J Invest Dermatol 111:900–902, 1998
mutations are clustered in the more internal parts of the rod domain,
in most cases within the 1B or 2B segments of K14. In contrast to
EBS-Dowling–Meara and EBS-K, mutations of the EBS-WC type are
situated outside the α-helical rod within the L12 linker region of K5
and K14 and the H1 domain of K5 (Chan et al, 1993, 1994; Rugg
et al, 1993; Ehrlich et al, 1995; Matsuki et al, 1995).
In this report we describe novel mutations in K5 and K14 genes in
four unrelated German families with EBS-WC in close vicinity of
previously reported mutations, supporting the observation that these
regions represent mutational hotspots for EBS-WC.
MATERIALS AND METHODS
Families Subjects to study were four German patients (two familiar and two
spontaneous) that showed the typical clinical features of EBS-WC such as onset
in early childhood or infancy, blistering restricted to palmoplantar regions,
worsening in hot weather, and absence of oral cavity lesions or milia (for
pedigrees, see Fig 1).
Between patients a, c, and d no striking differences in severity or frequency
of the disease could clinically be ascertained.
Individual b2 claimed that blistering was present already at birth and was
more generalized in early childhood. With this anamnesis, a K type cannot be
certainly excluded.
All analyzed family members were examined carefully by one of us (WK,
LBT, BPK).
Mutation detection Genomic DNA was isolated from ethylenediamine
tetraacetic acid blood samples. Exons 4–6 of K14 and Exons 1 and 5 of K5
were amplified by polymerase chain reaction using Taq DNA polymerase
(Boehringer, Mannheim, Germany). Primer sets were as follows: (i) exons 4–6
of K14, 59-TGA-CTG-TGG-ACT-GTC-CCT-GGC-TTG-CA-39 and 59-
TGG-GGG-GGG-CGG-ACT-AAG-GGG-AG-39. These primers have a high
homology to the K14 pseudogene. In order to diminish pseudogene contamina-
tion (which in fact can be seen in Fig 2a, C→A in 274) the annealing
temperature in polymerase chain reaction was upregulated as high as possible.
(ii) Exon 1 of K5, 59-GCT-GGC-TTT-GGA-GGT-GGC-TTC-GGT-G-39,
and 59-TGC-AGC-AGG-GTC-CAC-TTT-GTT-TCC-AGA-39; and (c) exon
5 of K5, 59-AGA-ACC-AGA-TGA-CCG-ACT-CC-39 and 59-GAG-ACA-
GTC-ATC-AGA-GCA-CC-39.
Fifty microliter reactions containing 250 ng DNA, 200 nM of each primer,
200 µM of each dNTP, 10 mM Tris-HCl, 1.25 U Taq DNA polymerase with
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Figure 1. Pedigrees of studied German EBS-WC cases. Analyzed family
members are indicated by numbers.
Figure 2. Mutations in K5 and K14. Parts of DNA sequencing gels showing
the various detected point mutations in the L12 linker and H1 domain of K5
and K14, respectively. An affected and unaffected family member of each family
is shown. Arrows indicate the location of the mutation.
optimized MgCl2 and KCl concentrations and pH were initially denaturated at
94°C for 2 min, followed by 35 cycles of 1 min at 94°C, 1 min at 56°C
(K5Exon5) or 64°C (K5Exon1,K14Exon4–6) and 1.5 min at 72°C, followed
by a 7 min final extension step at 72°C. After treatment with shrimp alkaline
phosphatase and exonuclease 1 the polymerase chain reaction products were
directly sequenced applying the Sequenase polymerase chain reaction product
sequencing kit (USB/Amersham Life Science, Cleveland, OH).
RESULTS
Sequence analyses of K5 and K14 in four German EBS-WC cases
detected novel point mutations in the L12 linker-domain of K14
Figure 3. Summary of reported EBS-WC mutations in K5 and K14.
Schematical demonstration of the position of reported EBS-WC mutations in
the K5 and K14 protein chain. The numbers in parentheses indicate the number
of distinct cases if greater than one.
(D273G) (Fig 2a), the H1 domain of K5 (P156L) (Fig 2d), and the
L12 linker domain of K5 (M327K and D328H) (Fig 2b, c). The novel
K14 mutation of patient a1 is an A to G transversion at base 3288
(EMBL accession code: J00124), leading to exchange of an aspartic
acid to glycine within the protein. The mutation was also found in
the patient’s affected father, whereas the clinically unaffected mother
did not show the mutation. The novel K5 mutations of patients b2
and c1 altered methionine to lysine at residue 327 (1885T→A) resp.
aspartic acid to histidine at residue 328 (1887G→C) (EMBL-AC:
M28496). The latter was also found in the patient’s affected sister. The
mutation found in patient d5 is located in the H1 domain of K5
(1359C→T) at residue 156 and leads to a conversion of a proline to
a leucine. None of the mutations occurred in the examined unaffected
family members. To discount common polymorphisms we employed
restriction enzymes that specifically cut either the mutated or the wild-
type sequence. These were HaeII for mutation D273G, NcoI for
mutations M327K and D328H (cuts only the wild-type but none of
both mutations), and BseRI for mutation P156L. We could exclude
the presence of each of the mutation in 50 unrelated controls.
DISCUSSION
The pathogenetical relevance of the here described mutations is
supported by two lines of evidence. In all of our and earlier analyzed
cases of EBS-WC, there existed a strict correlation between the mild
clinical phenotype and the region of the detected mutation in K5 or
K14. Furthermore, all these mutations lead to the substitution of highly
conserved amino acid residues and are located either nearby or at the
same codons as previously described mutations. Figure 3 demonstrates
schematically the clustering of so far reported EBS-WC mutations at
three distinct protein structural domains of K5 and K14.
How these defective keratins impair normal KIF stability is not well
understood. Indications of how the H1 domain might be involved in
the organization of KIF were gained by recent chemical cross-linking
studies (Steinert and Parry, 1993; Steinert et al, 1993). This model of
KIF structure postulates linear arrays of keratin dimers. The end of the
1A domain of one dimer is connected by a 10–11 residue head-to-tail
overlap to the 2B end of the next dimer in line. Juxtaposed dimer
chains are predicted to be directed anti-parallel with the keratin dimers
either aligned staggered or in close axial register. In this model the H1
subdomain could play a critical role for lateral associations between
the juxtaposed keratin dimers.
There are also indications that changes in the L12 linker domain
may interfere with the packing of protofilaments. In the anti-parallel
staggered mode of alignment, the L12 linker comes very close to the
head-to-tail overlap region of the neighbored row of dimers and would
be therefore in a position to promote appropriate lateral associations.
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For over 10 y there have also been suggestions from computer
predictions of secondary structure that the L12 linker may form a
β-sheet motif in the alternating 4–5 times repeated apolar–polar stretch.
In the mode of alignment where dimers are in close axial register this
β-sheet structure could form a stable cluster with the sheet motif of the
adjacent dimer (Peter Steinert, personal communication). Nevertheless,
these predictions of the conformation of the L12 linker are still
speculative at this stage and further experiments are needed to under-
stand its function for KIF stability.
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